Discounted Cash Flow Rating
Neutral
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Sell
C
Generation Bio Co. Common Stock (GBIO)
Pharmaceutical Preparations
Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina related diseases.
301 BINNEY STREET
CAMBRIDGE, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/12/2020
Market Cap
167,807,399
Shares Outstanding
66,080,000
Weighted SO
66,078,017
Total Employees
N/A
Upcoming Earnings
08/07/2024
Beta
2.8320
Last Div
0.0000
Range
0.86-5.496
Chg
-0.1257
Avg Vol
126722
Mkt Cap
167807399
Exch
NASDAQ
Country
US
Phone
617 655 7500
DCF Diff
2.8666
DCF
-0.2266
Div Yield
0.0000
P/S
12.7378
EV Multiple
-2.1602
P/FV
1.4495
Div Yield %
0.0000
P/E
-1.0559
PEG
-0.0773
Payout
0.0000
Current Ratio
7.4172
Quick Ratio
7.4172
Cash Ratio
0.9467
DSO
37.0430
DIO
0.0000
Op Cycle
37.0430
DPO
119.4978
CCC
-82.4547
Gross Margin
0.5572
Op Margin
-8.4927
Pretax Margin
-12.0256
Net Margin
-12.0256
Eff Tax Rate
-0.0339
ROA
-0.5972
ROE
-0.9286
ROCE
-0.4758
NI/EBT
1.0000
EBT/EBIT
1.4160
EBIT/Rev
-8.4927
Debt Ratio
0.3542
D/E
0.8141
LT Debt/Cap
0.4251
Total Debt/Cap
0.4488
Int Coverage
-6.9696
CF/Debt
-1.0974
Equity Multi
2.2985
Rec Turnover
9.8534
Pay Turnover
3.0545
Inv Turnover
0.0000
FA Turnover
0.3361
Asset Turnover
0.0497
OCF/Share
-1.5497
FCF/Share
-1.6568
Cash/Share
3.2608
OCF/Sales
-7.8265
FCF/OCF
1.0691
CF Coverage
-1.0974
ST Coverage
-11.9432
CapEx Coverage
-14.4771
Div&CapEx Cov
-14.4771
P/BV
1.4495
P/B
1.4495
P/S
12.7378
P/E
-1.0559
P/FCF
-1.5224
P/OCF
-1.6224
P/CF
-1.6224
PEG
-0.0773
P/S
12.7378
EV Multiple
-2.1602
P/FV
1.4495
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
11.95K Shares Bought (43.60 %)
15.46K Shares Sold (56.40%)
3 - 6 Months
2.23M Shares Bought (99.28 %)
16.09K Shares Sold (0.72%)
6 - 9 Months
16.38K Shares Bought (43.60 %)
21.19K Shares Sold (56.40%)
9 - 12 Months
196.38K Shares Bought (87.56 %)
27.91K Shares Sold (12.44 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2021 | 2022 | 2023 | 2024 | 2024 | 1970 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 2.88M | ▲ 4.06M | ▼ |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | ▲ 1.35M | ▲ 1.97M | ▼ 1.31M | ▼ |
Gross Profit | 0.00 | 0.00 | 0.00 | ▼ -1.35M | ▲ 912.00K | ▲ 2.75M | ▼ |
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 0.32 | ▲ 0.68 | ▼ |
Research And Development Expenses | 12.73M | ▲ 16.37M | ▲ 21.85M | ▼ 21.61M | ▲ 27.92M | ▼ 13.02M | ▼ |
General And Administrative Expenses | 3.43M | ▲ 7.97M | ▲ 9.10M | ▲ 13.08M | ▲ 13.38M | ▼ 10.43M | ▼ |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -311.00K | ▼ |
Selling General And Administrative Expenses | 3.43M | ▲ 7.97M | ▲ 9.10M | ▲ 13.08M | ▲ 13.38M | ▼ 10.12M | ▼ |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 56.93M | ▼ |
Operating Expenses | 16.16M | ▲ 24.35M | ▲ 30.95M | ▲ 34.69M | ▲ 41.30M | ▼ 23.14M | ▼ |
Cost And Expenses | 16.16M | ▲ 24.35M | ▲ 30.95M | ▲ 34.69M | ▲ 41.30M | ▼ 24.45M | ▼ |
Interest Income | 0.00 | 0.00 | ▲ 3.00K | ▲ 2.28M | ▲ 3.24M | ▼ 3.09M | ▼ |
Interest Expense | 0.00 | ▲ 591.00K | ▼ -50.00K | ▲ 2.28M | ▲ 16.05M | ▼ 0.00 | |
Depreciation And Amortization | 679.00K | ▲ 991.00K | ▲ 1.17M | ▲ 1.35M | ▼ 1.33M | ▼ 1.31M | ▼ |
Ebitda | -15.48M | ▼ -24.35M | ▼ -30.95M | ▼ -34.69M | ▼ -37.10M | ▲ -19.08M | ▼ |
Ebitda Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -12.89 | ▲ -4.70 | ▼ |
Operating Income | -16.16M | ▼ -24.35M | ▼ -30.95M | ▼ -34.69M | ▼ -38.42M | ▲ -20.39M | ▼ |
Operating Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -13.35 | ▲ -5.02 | ▼ |
Total Other Income Expenses Net | 95.00K | ▲ 119.00K | ▼ 3.00K | ▲ 2.28M | ▲ 3.24M | ▼ -54.15M | ▼ |
Income Before Tax | -16.06M | ▼ -24.23M | ▼ -30.94M | ▼ -32.41M | ▼ -35.19M | ▼ -74.54M | ▼ |
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -12.23 | ▼ -18.36 | ▼ |
Income Tax Expense | 0.00 | ▼ -991.00K | ▼ -1.17M | ▼ -2.28M | ▲ 5.40M | ▼ 0.00 | |
Net Income | -16.06M | ▼ -24.23M | ▼ -30.94M | ▲ -30.12M | ▼ -35.19M | ▼ -74.54M | ▼ |
Net Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -12.23 | ▼ -18.36 | ▼ |
Eps | -0.51 | ▼ -0.53 | ▼ -0.54 | ▲ -0.51 | ▼ -0.53 | ▼ -1.12 | ▼ |
Eps Diluted | -0.51 | ▼ -0.53 | ▼ -0.54 | ▲ -0.51 | ▼ -0.53 | ▼ -1.12 | ▼ |
Weighted Average Shs Out | 31.39M | ▲ 45.86M | ▲ 56.67M | ▲ 59.41M | ▲ 66.06M | ▲ 66.43M | ▼ |
Weighted Average Shs Out Dil | 31.39M | ▲ 45.86M | ▲ 56.88M | ▲ 59.41M | ▲ 66.06M | ▲ 66.43M | ▼ |